http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2493837-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb6de2010a5bbb03e2bdd25de56b80d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26a31fa45f98efbee062b47ca2cc88c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aab328832d48acad4d3555ad5ba716e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0915e28fb2e347a191d4d0648989d835
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-63
filingDate 2012-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c43945d4781fd32dd6db80f0e39b26a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9695c755ba35f188aca06f8973dfbbf7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f62312400a3f4f5325c7785c42e48765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a4457ad3245cf6138996dd164cc71eb
publicationDate 2013-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2493837-C1
titleOfInvention Anti-inflammatory ointment
abstract FIELD: medicine, pharmaceutics. n SUBSTANCE: invention relates to field of chemical-pharmaceutical industry, in particular, to pharmaceutical compositions in form of ointments, which have anti-inflammatory, anesthetic, antimicrobial, wound-healing and regenerating action. Anti-inflammatory ointment includes sulfanilamide (sulfidine), racemic camphor, vaseline, rendered pork fat, additionally contains antioxidants - butylhydroxyanisol and butylhydroxytoluene. Sulfanilamide is introduced into composition of ointment in micronised condition, and not less than 90% of particles have size to 20 mcm and not more than 10% of particles have size to 90 mcm. n EFFECT: increase of ointment efficiency. n 2 cl, 4 ex, 4 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GR-1009789-B
priorityDate 2011-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2401104-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-83402-C2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410249495
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31404
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID13429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66895
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24667
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448352729
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136400727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535552
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID13429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552698
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2537
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494150

Total number of triples: 44.